San Diego Education Report

Chief Executive Officer (CEO) for the
Faculty Practice/ Dean of Clinical Affairs
Job #JPF00466

School of Medicine - VC-HEALTH SCIENCES

Recruitment Period
Open Nov 1, 2013 through Feb 28, 2014
Last review date was November 22nd, 2013
. Your
application may or may not be reviewed by the search

The UCSD Office of the Vice Chancellor, Health
Sciences is recruiting for a Chief Executive Officer
(CEO) for the Faculty Practice/ Dean of Clinical Affairs
who will work collaboratively with the Vice Chancellor
for Health Sciences and the CEO for the Health
System in overseeing all aspects of Health Sciences
Faculty Practice. The CEO for the Faculty Practice is
responsible for ensuring the successful Clinical
Operations of the UCSD Faculty Practice including
Quality of Care, Clinical Compliance, Privacy, Clinical
Residency, Clinical Service Agreements, and
Telemedicine. The University of California, San Diego
is committed to academic excellence and diversity
within the faculty, staff, and student body.

University of California, San Diego is an Equal
Opportunity Employer
AP On-Line Recruit
University of California, San Diego
© 2007-2014 The Regents of the University of
California. All rights reserved.

Thomas Moore, MD
Dean of Clinical Affairs and Chief Executive Officer of
the UC San Diego Faculty Practice

As Dean of Clinical Affairs and Chief Executive Officer
of the UC San Diego Faculty Practice, Dr. Moore
provides leadership of UC San Diego Medical Group,
an inpatient and outpatient physician practice. In this
role, he works closely with department chairs and chief
administrative officers to implement inpatient and
ambulatory strategies to enhance clinical operations
and to ensure an effective care delivery network,
community care program, and a comprehensive
ambulatory risk management program. Additionally,
Dr. Moore is responsible for ensuring that UC San
Diego Health System’s clinical programs and activities
achieve the highest standards of service, quality,
safety, compliance and overall performance, and are
integrated to support the unique needs of an
academic health system.

Dr. Moore served as chair of the Department of
Reproductive Medicine for 18 years, and chair of the
Women and Infants Clinical Program Council. He is
board-certified in obstetrics and gynecology, and
maternal-fetal medicine, and specializes in high-risk
pregnancies and diseases that affect the fetus. As a
practicing physician, Dr. Moore will continue his
dedication to helping women understand how
pregnancy affects their bodies and what they can do
to help ensure healthy outcomes for their unborn
babies. His research interests center on optimal
management of diabetes in pregnancy, prenatal
diagnosis of fetal abnormalities and the clinical
quantitation and assessment of amniotic fluid volume.

Dr. Moore served 25 years in the U.S. Navy and
participated in two executive development programs
through the Wharton School of Business and the
Harvard School of Business. During his medical
training, he completed a fellowship in Maternal-Fetal
Medicine at UC San Diego School of Medicine after
doing his residency and internship in Obstetrics and
Gynecology at the Naval Medical Center San Diego.
Dr. Moore earned his medical degree and graduated
cum laude from Yale University in Connecticut. He has
authored and co-authored many peer-reviewed journal
articles and chapters in major medical textbooks,
including co-editing Creasy and Resnik’s Maternal
Fetal Medicine and contributing to Neonatal-Perinatal
Medicine and Diseases of the Newborn.

Nationally, Dr. Moore has served as officer and
participant on numerous boards and advisory panels
including those of the American Board of Obstetrics
and Gynecology, American Gynecological and
Obstetrical Society, and National Institutes of Health
Study. Dr. Moore has been ranked several times as
one of the top obstetricians and gynecologists in the
nation by U.S. News & World Report, as well as been
named repetitively as a “Top Doc” in San Diego
Magazine’s “Physicians of Exceptional Excellence”
annual survey performed in collaboration with the San
Diego County Medical Society. Most recently he
received the Louis M. Hellman, MD Midwifery
Partnership Award from the American College of
Obstetricians and Gynecologists.

When not at work, Dr. Moore enjoys sailing,
photography, playing jazz music and spending time
with his wife Peggy, five children and 12 grandchildren.

Thomas Moore
Chairman, Department of Reproductive Medicine
Division of Perinatal Medicine

(619) 543-7900
(619) 543-3703
Medical Education

MD, Yale University (Cum Laude), 1979
Obstetrics and Gynecology Residency @ Naval
Hospital San Diego,1979-1983
Maternal-Fetal Medicine Fellowship @ UCSD School of
Medicine, 1983-1985

Research Interests

Clinical quantitation and assessment of amniotic fluid
Regulation of amniotic fluid volume
The contribution of fetal urinary function and maternal
vascular tonicity to amniotic fluid volume.

Clinical Specialties

All aspects of Maternal-Fetal Medicine, especially
including fetal movement, diabetes and pregnancy,
amniotic fluid volume, fetal diagnosis.
Board Certifications

Obstetrics and Gynecology/Maternal-Fetal Medicine.
Classes regularly taught

Maternal Adaptation to Pregnancy
Fetal Renal Development
Fetal Hematology
Use and Abuse of the Amniotic Fluid Index
Sonography in Early Pregnancy Evaluation
Is Technology Interfering with Childbirth?
Patterns of Uterine Contractions in Normal Pregnancy:
Lessons for the Treatment of Preterm Labor
Trauma in Pregnancy
New Approaches to Minimizing Morbidity and Diabetic
Postdates Paradoxes
Obstetric Emergencies

Recent Publications
Peer-Reviewed Articles:

Sohl BD, Scioscia AL, Budorick NE, Moore TR. Utility of
minor ultrasonographic markers in the prediction of
abnormal fetal karyotype at a prenatal diagnostic
center. Am J Obstet Gynecol 1999;181(4):898-903.
Wolf RB, Moise KJ, Richter PJ, Moore TR, Brace RA.
Antibody-induced platelet destruction in fetal sheep.
Submitted to Am J Obstet Gynecol, 1999.
Song T-B, Moore TR, Lee J-Y, Kim Y-H, Kim E-K. Fetal
weight prediction by thigh volume measurement with
three-dimensional ultrasonography. Obset Gynecol 96
(2):157:161, 2000.
Adams-Chapman I, Vaucher YE, Bejar RF, Benirschke
K, Baergen RN, Moore TR. Maternal floor infarction of
the placenta: association with central nervous system
injury and adverse neurodevelopmental outcome. J
Perinatol 22(3):236-41, 2002.
Moore TR. A comparison of amniotic fluid fetal
pulmonary phospholipids in normal and diabetic
pregnancy. Am J Obstet Gynecol 186(4):641-50, 2002.

Former UCSD Dean of Clinical
Affairs Dies in Africa
By Brandi Powell and Monica Garske
NBC San Diego
Sep 4, 2013

The University of California San Diego’s former dean
of clinical affairs, Thomas ‘Tom’ McAfee, has died,
NBC 7 confirmed.

According to Debra Kain, director of Health Sciences
Research Communications at UC San Diego, McAfee
recently died in an accident while on vacation in
Tanzania, Africa. His cause of death has not yet been

Kain says McAfee’s last day with UC San
Diego was fairly recent.

He was set to begin a new job at the University
of Southern California this Tuesday, Sept. 3, as
the CEO of the Keck Medicine of USC Medical

In his roles at UC San Diego, McAfee was the dean of
Clinical Affairs for the UC San Diego Health
Sciences, as well as chief executive officer for
UC San Diego Faculty Practice.

He provided leadership for UC San
Diego Medical Group, an inpatient and
outpatient physician practice.
He also
served as president of UC San Diego Ambulatory
Surgery Center.

According to his official UCSD biography, McAfee was
recruited in 2002 as UCSD Health Sciences’ first
Prior to joining UCSD, he served
as associate chief medical officer at UC San

On Sunday, McAfee’s UC San Diego colleagues, David
Brenner, MD, Paul Viviano and
Larry Friedman, MD,
released the following email to faculty and staff at UC
San Diego Health Sciences:

“It is with regret and personal sadness that we inform
you that Dr. Thomas McAfee, until very recently, the
Dean of Clinical Affairs for UC San Diego Health
Sciences and CEO for UC San Diego Faculty Practice,
was killed in an accident while on vacation in Africa.
We have no other details at present.

University dean 'trampled to death by an
ELEPHANT on luxury African vacation' just
three days before he was due to start his new
Daily Mail
4 September 2013

Dr. Thomas McAfee, 58, died on Saturday after being
trampled by an elephant in Tanzania...
San Diego
Education Report
News, information and ideas about our
education system, courts and health care
by Maura Larkins
Thank Heaven for
Insurance Companies blog
Blog: Kaiser Permanente
Problems at Garfield Center
in Kearny Mesa
Filing a complaint
Kaiser Permanente links
UCSD Health System
UC,growth in management and administrator salaries
Blog posts re UCSD (Health
Blog posts re UCSD (Thank
Blog posts re UCSD (SDER)
Mark Harrison Appointed
CFO of UC San Diego
Health Sciences
March 23, 2015  |  Jackie Carr
UCSD press release

Mark Harrison has been appointed as
the new chief financial officer (CFO)
for UC San Diego Health Sciences,
effective March 23, 2015. As CFO,
Mark will collaborate with university
leadership to ensure the strong
financial health of the globally-
recognized UC San Diego Health
Sciences enterprise, overseeing a
budget of more than $2.4 billion.

“We are pleased to have Mark join UC
San Diego Health Sciences at a critical
juncture of growth and integration of
the health system’s clinical network,”
said Paul Viviano, CEO, UC San Diego
Health System and associate vice
chancellor, UC San Diego Health
Sciences. “Mark’s extensive
experience as an accomplished leader
in the complex sector of health, finance
and performance management will
enhance our financial stability and help
preserve our academic mission while
providing patients the best value for

Harrison will develop and implement
strategies and budgets to
achieve UC San Diego Health
Sciences’ financial goals and
objectives, as well as consistent
systems of financial reporting
standards and controls across UC
San Diego School of Medicine,
Skaggs School of Pharmacy and
Pharmaceutical Sciences, UC San
Diego Medical Group, and UC San
Diego Health System.

Harrison will be responsible for
efficient and effective
funds flow between UC San
Diego School of Medicine and
UC San Diego Health System
as well as cost control and
standardized reporting among the
organizations. He will also oversee the
implementation and operations of
integrated financial support
departments that will function as
shared services for accounting,
procurement, billing, decision support
and contracting.

Previously, Harrison was principal and
founder of Apex Healthcare Group, a
company that advises boards and
CEOs of health care companies, and
the senior vice president, Investments
for Growth, Quality and Total Cost of
Care Division at Accretive Health, Inc.,
which focused on the development of
population health offerings designed
for health systems, medical groups
and health plans.

In his prior role as CFO of DaVita, a
Fortune 500 public company
specializing in renal care, Harrison’s
responsibilities included investor
relations, general and administrative
expense management, risk
management and certain strategic
roles, in addition to the finance
functions. Prior to DaVita, he served
as the CFO of Allina Hospitals and
Clinics, a large integrated delivery
system based in Minneapolis,
Minnesota. His executive oversight
responsibilities at Allina included
strategy and business development,
internal consulting, supply chain,
revenue cycle and payer contracting,
as well as the finance function. Earlier
in his career, Harrison was a founder
and principal of Shattuck Hammond
Partners, a health care specialty
investment bank.

Harrison received his Master in
Business Administration and Master in
Public Health degrees from Columbia
University in New York after obtaining
his Bachelor of Arts degree in Biology
and Psychology from Bowdoin College
in Brunswick, Maine. He has been an
active public speaker throughout his
career and received the Healthcare
Financial Management Association’s
annual National Institute Distinguished
Speaker Award in 2001. He has also
produced many publications and was
selected to receive a $570,000
research grant from the California
Healthcare Foundation to assess the
financial health of California’s hospitals.

UC San Diego Health Sciences is
internationally recognized as a place
where discoveries are delivered –
bringing breakthroughs from the
research lab to patients' bedsides.
Established in 1968, UC San Diego
School of Medicine is consistently
ranked among the top research-
intensive medical school programs in
the country by U.S. News & World
Report and, in 2014, had the ninth
highest National Institutes of Health
total funding of 136 schools of
medicine in the U.S. Skaggs School of
Pharmacy and Pharmaceutical
Sciences opened in 2000 as the only
public school of pharmacy in the
region, and the second in the state of

UC San Diego Health System, the
region's only academic health system,
is consistently ranked #1 in the San
Diego area by U.S. News & World
Report with national rankings in 11
adult specialties, placing it among the
top 50 hospitals in the country. UC San
Diego Health System was recently
named by Truven Health Analytics as
one of the nation’s Top 100 Hospitals
based on measures such as patient
care, operational efficiency and
financial stability. Additionally,
Leapfrog Group named UC San Diego
Health System as a Top Hospital, with
‘A’ Hospital Safety Scores, placing it
among the safest hospitals in the
United States.

UC San Diego Health System is
comprised of UC San Diego Medical
Center in Hillcrest and UC San Diego
Thornton Hospital, Moores Cancer
Center (one of only 41 National
Cancer Institute-designated
comprehensive cancer centers in the
country), Shiley Eye Institute, Sulpizio
Cardiovascular Center and Jacobs
Medical Center (opening 2016) in La
Jolla, as well as other primary and
specialty practices located throughout
Southern California.
updated Dec. 13, 2015

UCSD's $516,000 temporary executive
Interim health system shoe-filler collects retroactive six-
figure cash
By Matt Potter
San Diego Reader
Dec. 11, 2015

The intrigue surrounding the saga of
UCSD Health's departed top man Paul
Viviano continues, with a lengthening
search underway to fill the vacancy, and
approval by U.C. regents of a $516,000
interim appointment.

...Since Viviano's summer resignation, the chief
executive part of his job has been filled by
who worked under him as executive director
of Strategic and Business Development.

Ms. Maysent has been serving as the CEO of UC San
Diego Health System since Mr. Viviano’s departure,
without any additional compensation beyond her
current salary of $299,252," says a November 20
regents report...
updated Aug. 15, 2015

David Brenner
Vice Chancellor
UC San Diego Health Sciences
Dean, UC San Diego School of Medicine

David Brenner is vice chancellor for Health
Sciences and dean of the School of Medicine at the
University of California, San Diego. In this role, he
leads the School of Medicine, Skaggs School of
Pharmacy and Pharmaceutical Sciences at
University of California, San Diego, and UC San
Diego Health System
Paul Viviano (see box below) has been replaced by two people.
[Health System CEO] Viviano abruptly departs UCSD in
turmoil’s midst
By Matt Potter
San Diego Reader
July 9, 2015
...Starting August 24, Viviano will become the new president and chief executive officer
of the Children’s Hospital of Los Angeles.
[Viviano's departure to USC seems to have coincided with
UCSD's decision to sue USC. Perhaps Viviano did not support
the decision to sue.]
Paul Viviano--(Former) Chief Executive Officer and
Associate Vice Chancellor
News Release
Date: May 01, 2012
Paul S. Viviano Named New CEO of UC San Diego Health System
Paul S. Viviano has accepted the position as the new CEO of UC San Diego
Health System and associate vice chancellor for Health Sciences. His
appointment was approved by the UC Board of Regents, and will
commence June 1, 2012.
Forbes: ...Previously, he served as Chairman of the Board and Chief
Executive Officer of Alliance HealthCare Services from 2003 to June 2012...]
Patricia Maysent
Dr. Thomas Moore
Patty Maysent, MPH, MBA
Chief Executive Officer, UC San Diego Health
Updated Oct. 29, 2016

Patty Maysent is the chief executive officer for UC San Diego Health, which she joined in June
2012 as chief of staff and then became chief strategy officer in 2013. Maysent brings more than
25 years of executive experience in hospital and health services management to these positions,
including having served as CEO of St. Jude Medical Center.

Maysent is responsible for the performance and operations of UC San Diego Health, which
employs more than 7,500 team members and has an operating budget in excess of $1.7 billion.
Maysent will also continue to move the region's only academic medical center forward in its
tripartite mission of delivering outstanding patient care, groundbreaking research and inspired

Maysent is the principal architect of UC San Diego Health's strategic plan, which concentrates on
four main areas: clinical excellence, patient experience, performance management and growth.  
Additionally, she has managed the development of the clinical programs councils and related
specific clinical program strategic plans.

Throughout her time at UC San Diego Health, Maysent has been instrumental in improving the
delivery of care by developing significant collaborations that have increased access to UC San
Diego Health's services. Among them are new programs and strategic partnerships with Rady
Children's Hospital and Scripps Health; an affiliation agreement with El Centro Regional Medical
Center and Tri-City Healthcare District; clinical affiliations with Temecula Valley Hospital and
Eisenhower Medical Center; and a joint venture with home health care provider AccentCare.

In addition, Maysent has expanded the UC San Diego Health Physician Network, a collective of
regional health care providers including UC San Diego Health and faculty physicians, community
hospitals, medical groups and physicians based in San Diego, Riverside and Imperial Counties.
Members of the physician network become part of a clinical integration network that collaborates
on developing shared systems, infrastructure, care pathways and quality initiatives to provide
high-value health care to patients, employers and health plans.

Maysent's extensive experience in community partnerships also resulted in UC San Diego Health
partnering with high profile organizations, such as the San Diego Chargers and United States
Olympic Committee. These collaborative efforts have allowed UC San Diego Health to expand
services within the community and provide medical care to some of the world's greatest athletes.

Maysent is also credited with achieving financial change by creating a culture of operational
accountability, excellence and efficiency at UC San Diego Health. As CEO, she will continue to
drive forward-thinking results and position UC San Diego Health for the future – clinically,
academically and financially.

Prior to joining UC San Diego Health, Maysent served in several executive roles, including the
aforementioned position as CEO of St. Jude Medical Center where she negotiated and built the
St. Jude Medical Practice Foundation, which was a novel physician integration concept at the
time. She also served as a consultant for University of Southern California's Keck Medical Center
and Alliance Healthcare Services, a leading provider of advanced outpatient diagnostic imaging
and radiation oncology services.

Maysent holds a Bachelor of Arts degree in human biology from Stanford University, and
master's degrees in business administration and public health from University of California, Los
Angeles. She serves on the board and executive committee of the Boys and Girls Club of San

An advocate of healthy living and exercise, she is an avid swimmer, paddler and surfer. As a
senior in high school, she was the national champion in the 200 breaststroke in 1979, and a
bronze medalist in the Pan American games. At Stanford, she was a four-year All-American and
team captain of Stanford's NCAA National Championship Swim Team in 1983.
Patty Maysent Named CEO of UC San Diego Health
January 21, 2016  
Jackie Carr
UCSD Newsroom

Patty Maysent has accepted the position as CEO of UC San Diego Health, the region’s only
academic health system. Her appointment was approved by the UC Board of Regents and will
commence January 21, 2016...
Lori R. Donaldson
Chief Financial Officer
UC San Diego Health
updated Oct. 29, 2016

Lori R. Donaldson is the chief
financial officer (CFO) at UC San
Diego Health, the region’s only
academic health system. As a
member of the senior leadership
team, she is responsible for the
development and implementation
of the financial strategies,
operating and capital budgets,
and system of financial reporting
and controls that support the
overall vision, mission, goals and
objectives of UC San Diego
Health. She is actively involved in
planning and executing strategic
partnerships and oversees
financial planning and funding
strategies in support of UC San
Diego Health’s large capital
projects, including Jacobs Medical

Ms. Donaldson oversees a budget
of more than $1 billion. She is
actively involved in the University
of California’s Leveraging Scale
for Value initiative to encourage
collaboration among the UC
health centers and increase
efficiency and operational
excellence. Under Donaldson’s
guidance, UC San Diego Health
has consistently reported margins
in excess of industry averages.
She was named CFO of the Year
by the San Diego Business
Journal in 2015.

Ms. Donaldson came to UC San
Diego Health in 1990 and served
as its controller for 13 years prior
to her appointment as CFO in July
2010. She has extensive
experience in all aspects of
financial management, including
financial accounting, revenue
cycle and budget operations,
business planning, external
financing, capital planning and
long-term financial forecasting in
both for-profit and nonprofit
organizations.  Prior to joining UC
San Diego Health, she was an
assistant vice president of
financial planning and analysis for
a large financial institution.
updated Oct. 29, 2016
Angela Scioscia, MD
Chief Medical
Officer (CMO)
UC San Diego
Health System
downloaded Aug. 17, 2014
updated Oct. 29, 2016

Angela Scioscia, MD,
joined the UC San Diego
faculty in 1989,
and has been chief medical
officer (CMO)
of UC San Diego Health
System since 2004.

As CMO, she works to ensure
that the highest safety and
quality standards are being
met, and that the entire staff
works together to provide
patient-centered care through
a multidisciplinary and
integrated approach.

Dr. Scioscia, a professor in
reproductive medicine, is
board-certified in obstetrics
and gynecology, maternal-fetal
medicine and medical
genetics. She is actively
involved in the training of
medical students and
residents. Prior to assuming
the role of chief medical
officer, she was the director of
the UC San Diego Fetal
Diagnosis and Treatment
Center for 15 years.

Dr. Scioscia completed her
internship, residency and two
fellowships at Yale University
School of Medicine. She
earned her medical degree at
the University of Pennsylvania
in Philadelphia and her
Bachelor’s of Arts at the
University of Virginia in

Dr. Scioscia participates in
several professional societies,
including the Society of
Maternal-Fetal Medicine, the
American Society of Human
Genetics, and the American
College of Obstetricians and
Gynecologists. She is the
recipient of numerous awards,
including the San Diego
Business Journal’s “Women
Who Mean Business” Award in
2009. She was nominated for
Athena San Diego’s Individual
in Education Pinnacle Award in
2006. Athena San Diego is the
premier organization for
executive women in science,
technology, health care and

Dr. Scioscia is married to
Steven Plaxe, MD, director of
UC San Diego Health System’s
Division of Gynecologic
Oncology. In her leisure time,
she enjoys relaxing with her
husband and two daughters.
Medical Business
Medical School Rankings
Kaiser code of silence
Kaiser concealing
medical records
Healthcare Watchdogs

Healthcare cutting costs

Balance billing

Health insurance
Medical Board

Medical Association
Medical Business
Medical Cover-ups
Medical secrecy
Kaiser Cover-ups
Kaiser concealing
medical records
Blog posts re UCSD (Health
Blog posts re UCSD (Thank
Blog posts re UCSD (SDER)
UC Priorities, "Efficiencies"
CEO Faculty Practice
Thomas Moore, MD and
CFO Mark Harrison
UCLA urology
Code of silence
More University of California
UCLA Patient
American doctor settles
discrimination suit
Lawyers at UC
(UCLA no tort claim)
(UCLA lawsuits) 1
(UCLA lawyers) radiology
UCLA lawsuits 2
UC general counsel

UCLA Radiology and
Medical Records

UCLA CareConnect

UCLA Compliance

Dr. Robert Pedowitz
wins $10 million for
retaliation by UCLA for
blowing whistle on
industry payments to

Dr. Eugene
Washington, dean of
medical school

Dr. Andrew Saxon,
author of paper on
harmlessness of
indoor mold

UCLA conflict of

UCLA Cull case

UCLA culture:
contempt and racism?

UCLA Dermatology

UCLA Patient

UCLA Patrick Harron
to be arraigned in
burning death in
chemistry lab

UCLA contract
with Kaiser for
kidney transplants
UCSD Dermatology
UCSD Health System
UCSD lawsuits and
general counsel

UCSD donations

UCSD colonoscopies

UCSD Combined Program

UCSD rankings
Blog posts re UCLA lawsuits

Blog posts re UCLA

UCSD HIPAA violation
UCSD violation of HIPAA
UCSD partners
Bad doctors
UCSD profits and
UCSD (ethics)